Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
116
天
Differential in vivo tyrosine kinase inhibitor sensitivities of pediatric ABL‐class Ph‐like B‐acute lymphoblastic leukemia
作者
Ritul Sharma; Jackson K. Dardis; Huong Anh Mai; Camilo Arenas Merizalde; Cesca van de Ven; Diego A. Bárcenas López; Shubhmita Bhatnagar; Andishe Attarbaschi; Judith M. Boer; Monique L. den Boer; Sarah K. Tasian展开收起
作者单位
1. Division of Oncology and Center for Childhood Cancer Research Children's Hospital of Philadelphia Philadelphia Pennsylvania United States; 2. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands; 3. Department of Pediatric Hematology and Oncology St Anna Children's Hospital Vienna Austria; 4. Center for Translational Immunology, University Medical Center Utrecht The Netherlands; 5. Department of Pediatrics University of Pennsylvania School of Medicine Philadelphia Pennsylvania United States; 6. Abramson Cancer Center, University of Pennsylvania School of Medicine Philadelphia Pennsylvania United States展开收起
163
天
Targeted proteomics reveal histiocytosis‐associated neurodegeneration signatures
作者
Egle Kvedaraite; Magda Lourda; Johannes Bastiaan Munting; Matthias Papo; Martin Jädersten; Yoko Shioda; Kenichi Sakamoto; Daniel Martín Muñoz; Panagiotis Andriopoulos; Francesco Pegoraro; Evaldas Laurencikas; Ingrid Kühnle; Joakim Wille; Leonie Naeije; Helena Olkinuora; Indranil Sinha; Daniel W. Hagey; Selma Olsson‐Åkefeldt; Fleur Cohen‐Aubart; Gustaf Österlundh; Mattias Svensson; Ahmed Idbaih; Fredrik Piehl; Kaj Blennow; Henrik Zetterberg; Tatiana Greenwood von Bahr; Désirée Gavhed; Akira Morimoto; Julien Haroche; Jan‐Inge Henter展开收起
作者单位
1. Department of Pathology and Cancer Diagnostics Karolinska University Hospital Stockholm Sweden; 2. Unit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet Stockholm Sweden; 3. The Systems Virology Laboratory, Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet Stockholm Sweden; 4. Internal Medicine Department 2, French National Referral Center for Histiocytoses Sorbonne University, Assistance Publique–Hôpitaux de Paris, Pitié‐Salpêtrière Hospital Paris France; 5. Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet Stockholm Sweden; 6. Department of Hematology Karolinska University Hospital Stockholm Sweden; 7. Children's Cancer Center, National Center for Child health and Development Tokyo Japan; 8. Department of Pediatrics Shinshu University School of Medicine Matsumoto Japan; 9. Department of Neuroradiology and Pediatric Radiology Karolinska University Hospital Solna Stockholm Sweden; 10. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 11. Department of Hematology and Oncology, Meyer Children's Hospital IRCCS Florence Italy; 12. Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet Stockholm Sweden; 13. Division of Pediatric Hematology and Oncology Göttingen University Medical Center Göttingen Germany; 14. Childhood Cancer Center Skåne University Hospital Lund Sweden; 15. Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands; 16. Division of Pediatric Hematology‐Oncology and Stem Cell Transplantation, New Children's Hospital Helsinki University Hospital Helsinki Finland; 17. Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet Stockholm Sweden; 18. Department of Pediatrics, The Queen Silvia Children's Hospital University of Gothenburg Gothenburg Sweden; 19. Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet Karolinska University Hospital Stockholm Sweden; 20. Sorbonne Université, AP‐HP, Institut du Cerveau ‐ Paris Brain Institute ‐ ICM, Inserm, CNRS Hôpitaux Universitaires La Pitié Salpêtrière ‐ Charles Foix, Service de Neuro‐Oncologie‐Institut de Neurologie Paris France; 21. Department of Neurology Karolinska University Hospital Stockholm Sweden; 22. Neuroimmunology Unit, Center for Molecular Medicine, Karolinska Institutet Stockholm Sweden; 23. Department of Clinical Neuroscience, Karolinska Institutet Stockholm Sweden; 24. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg Mölndal Sweden; 25. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Gothenburg Sweden; 26. Institute of Neurology University College London London UK; 27. Pediatric Oncology, Astrid Lindgren Children's Hospital Karolinska University Hospital Stockholm Sweden; 28. Division of Pediatrics, Showa Inan General Hospital Komagane Japan展开收起
138
天
3D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patients
作者
Fabien Gava; Paul Marcoux; Neus Serrat; Pauline Gravelle; Sonia Quertinmont; Marie Tosolini; Carla Faria; Juan G. Valero; Christina Schniederjohann; Cathy Quelen; Fanny Bouquet; Catia Fonseca; Sylvia Herter; Laura C. Deak; Ron McCord; Eugene Chiang; Peter‐Martin Bruch; Loïc Ysebaert; Patricia Pérez‐Galán; Camille Laurent; Christine Bezombes展开收起
作者单位
1. Univ Toulouse, INSERM, CRCT Toulouse France; 2. Institut Claudius Regaud ‐ IUCT‐Oncopole, imCORE site Toulouse France; 3. Laboratoire d'Excellence ‘TOUCAN‐2' Toulouse France; 4. Institut Carnot Lymphome CALYM Pierre‐Bénite France; 5. Department of Pathology IUCT‐Oncopole Toulouse France; 6. Fundació Clínic per a la Recerca Biomèdica—Institut d'Investigacions Biomèdiques August Pi i Sunyer Barcelona Spain; 7. Centro de Investigación Biomédica en Red‐Oncología (CIBERONC) Madrid Spain; 8. Oncology Department UNIL‐CHUV Bernhard Gentner laboratory, Agora Research Center Lausanne Switzerland; 9. Department of Hematology Hospital Clínic Barcelona Spain; 10. Department of Hematology, Oncology and Clinical Immunology Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf Düsseldorf Germany; 11. Center for Integrated Oncology Aachen‐Bonn‐Cologne‐Düsseldorf (CIO ABCD) Düsseldorf Germany; 12. Molecular Medicine Partnership Unit (MMPU) Heidelberg Germany; 13. Department of Medicine V Heidelberg University Hospital Heidelberg Germany; 14. F.Hoffmann‐La Roche Zurich Switzerland; 15. Roche Pharma Research and Early Development Roche Innovation Center Zürich Schlieren Switzerland; 16. Genentech San Francisco California USA; 17. Department of Hematology IUCT‐Oncopole Toulouse France展开收起
108
天
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long‐term results from FIL‐FLAZ12 Phase III trial
作者
Rita Tavarozzi; Andrea Evangelista; Manuela Zanni; Chiara Consoli; Alessandra Tucci; Barbara Botto; Silvia Bolis; Pietro Lauzzana; Vittorio Ruggero Zilioli; Benedetta Puccini; Annalisa Arcari; Vincenzo Pavone; Gloria Margiotta‐Casaluci; Monica Tani; Federica Cavallo; Antonio Pinto; Chiara Ghiggi; Domenico Pastore; Paolo Corradini; Andrés José María Ferreri; Angelo Palmas; Caterina Patti; Francesca Re; Fabio Benedetti; Giuseppe Milone; Stefano Luminari; Elsa Pennese; Elisa Bossi; Carola Boccomini; Antonella Anastasia; Chiara Bottelli; Donato Mannina; Samantha Pozzi; Catello Califano; Luca Arcaini; Flavio Falcinelli; Giuseppe Pietrantuono; Ilaria Del Giudice; Sara Usai; Jacopo Olivieri; Filippo Gherlinzoni; Attilio Olivieri; Tommasina Perrone; Fabrizio Pomponi; Giovannino Ciccone; Umberto Vitolo; Marco Ladetto展开收起
作者单位
1. Department of Translational Medicine University of Eastern Piedmont Novara Italy; 2. SCDU of Hematology AOU SS Antonio e Biagio e Cesare Arrigo Alessandria Italy; 3. Unit of Clinical Epidemiology AOU Città Della Salute E Della Scienza Di Torino and CPO Piemonte Turin Italy; 4. Department of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino Turin Italy; 5. Department of Hematology Spedali Civili Brescia Italy; 6. Struttura Complessa Ematologia AOU Città della salute e della scienza di Torino Turin Italy; 7. Division of Haematology SC Ematologia Fondazione Irccs San Gerardo dei Tintori Monza Italy; 8. Division of Hematology, Clinica Ematologica, Centro Trapianti e Terapie Cellulari Carlo Melzi DISM, Azienda Ospedaliero Universitaria S. M. Misericordia Udine Italy; 9. Division of Haematology ASST Grande Ospedale Metropolitano Niguarda Milan Italy; 10. Department of Haematology University of Florence Florence Italy; 11. Division of Hematology AUSL of Piacenza Piacenza Italy; 12. Hematology Unit Ospedale Guglielmo da Saliceto Piacenza Italy; 13. SC of Hematology A. O. C. Panico‐U. O. C Ematologia e Trapianto Tricase Italy; 14. Division of Hematology AOU Maggiore della Carità di Novara Novara Piedmont Italy; 15. Hematology Unit, Department of Oncology and Hematology “Santa Maria delle Croci” Hospital Ravenna Italy; 16. Department of Hematology Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico “Fondazione G Pascale” Naples Italy; 17. IRCCS Azienda Ospedaliera Metropolitana Divisione di Ematologia e Terapie Cellulari Genova Italy; 18. Division of Hematology Ospedale Antonio Perrino Brindisi Italy; 19. Division of Hematology IRCCS Istituto Nazionale Tumori Milan Italy; 20. Lymphoma Unit IUniversity Vita‐Salute San Raffaele Milan Italy; 21. Strategic Program on Lymphomas IRCCS San Raffaele Scientific Institute Milan Italy; 22. Unità di Ematologia e Trapianto di Midollo Osseo, San Francesco Hospital Nuoro Italy; 23. SCDU of Hematology “Villa Sofia – Cervello” Hospital Palermo Italy; 24. Department of Hematology A. O. U. di Parma Parma Italy; 25. Department of Medicine, Section of Hematology and Bone Marrow Transplant Unit University of Verona Verona Italy; 26. Division of Hematology and Program for Hematopoietic Transplantation Azienda Ospedaliera Policlinico Vittorio Emanuele Catania Italy; 27. Hematology Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia Reggio Emilia Italy; 28. SCDU of Hematology Presidio Ospedaliero Pescara Pescara Italy; 29. Hematology Unit Papardo Hospital Messina Messina Italy; 30. Dipartimento di Scienze Mediche e Chirurgiche Materno‐Infantili e dell'Adulto Università di Modena e Reggio Emilia Modena Italy; 31. Hematology Hospital “Andrea Tortora” Pagani Italy; 32. Department of Molecular Medicine University of Pavia Pavia Italy; 33. Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy; 34. Hematology and Bone Marrow Transplantation Azienda Ospedaliera Di Perugia Perugia Italy; 35. IRCCS CROB Referral Cancer Center of Basilicata Rionero in Vulture Italy; 36. Hematology, Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy; 37. Unit of Hematology and Bone Marrow Transplant AO Brotzu ‐ Ospedale Oncologico Businco Cagliari Italy; 38. Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale Udine Italy; 39. Division of Hematology Ca' Foncello Hospital Treviso Italy; 40. SCDU of Hematology Ospedale Regionale delle Marche Ancona Italy; 41. Department of Emergency and Organ Transplantation D. E. T. O., Hematology Section University of Bari Bari Italy; 42. Division of Hematology U.O.C. di Ematologia ‐ AULSS8 Berica Vicenza Italy; 43. Hematology IRCCS Candiolo Cancer Institute Turin Italy展开收起
251
天
Venetoclax plus azacitidine, low‐dose cytarabine, aclarubicin, and G‐CSF (VA‐CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single‐arm Phase II clinical trial
作者
Xiaoping Li; Qiurong Zhang; Xiaoyan Li; Lin Liu; Yonglin Shen; Yu Li; Lihui Peng; Chaoyang Zhou; Chie Qiu; Zhongtao Yuan; Shiqian Hou; Youcheng Wang; Lihua Zhang; Jingqiong Li; Liang Zhao; Qiuyuan Tang; Zucong Chen; Jing Feng; Xuejuan Zhang; Guoxiu Bao; Kui Zhang; Renpeng Zhang; Shiqi Li; Yingnian Chen; Jianhua Rao; Yancheng Dong; Dingsong Zhang; Yueyuan Wang; Aifang Li; Xi Ye; Lei Lei; Jiao Chen; Sufen Xu; Yanling Jin; Chaoen Zheng; Yang Liang; Sanbin Wang展开收起
作者单位
1. Department of Haematology 920th Hospital of Joint Logistics Support Force Kunming China; 2. Department of Haematology The First Affiliated Hospital of Dali University Dali China; 3. Department of Haematology The People's Hospital of Baoshan Baoshan China; 4. Department of Haematology and Oncology The Southern Central Hospital of Yunnan province Gejiu China; 5. Department of Haematology The People's Hospital of Chuxiong Chongxiong China; 6. Department of Haematology The Northeast Yunnan Center Hospital Zhaotong China; 7. Department of Haematology The People's Hospital of Yuxi City Yuxi China; 8. Department of Haematology and Oncology The People's Hospital of Lijiang Lijiang China; 9. Department of Haematology Xishuangbanna Dai Autonomous Prefecture People's Hospital Jinghong China; 10. Department of Haematology The People's Hospital of Dehong Prefecture Mangshi China; 11. Department of Haematology Dali Bai Autonomous Prefectue People's Hospital Dali China; 12. Department of Haematology The Second People's Hospital of Qujing Qujing China; 13. Department of Haematology The First People's Hospital of Zhaotong Zhaotong China; 14. Department of Haematology and Oncology The People's Hospital of Lincang Lincang China; 15. Department of Haematology Qujing Central Hospital of Yunnan Province Qujing China; 16. Department of Haematology and Rheumatism Immunity The People's Hospital of Puer Puer China; 17. Department of Hematological Oncology, State Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat‐sen University Cancer Center Guangzhou China展开收起
12
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天